Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.8.0.1
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Mar. 21, 2017
Feb. 02, 2017
Nov. 03, 2016
Mar. 31, 2016
Jun. 29, 2015
Feb. 02, 2015
Mar. 31, 2017
Jun. 30, 2017
May 31, 2017
Mar. 15, 2017
Mar. 13, 2017
Mar. 07, 2017
Dec. 31, 2016
Sep. 15, 2016
Jun. 30, 2016
Feb. 03, 2015
Consideration received       $ 5,000,000                        
Estimated value of accounts receivable       $ 8,700,000                        
Adjustment value of debt               $ 0             $ 1,500,000  
Investment percentage       20.00%                        
Debt term       6 months                        
Repayment of debt       $ 500,000                        
Debt instrument description       All payments recovered from the accounts receivable up to $5.25 million, if paid in full within six months, or $5.5 million, if not paid in full within six months, and (iii) 20% of all payments of the accounts receivable in excess of amounts received in (i) and (ii). On March 31, 2017, to the extent that the counterparty has not been paid $6.0 million, the Company was required to pay the difference, plus 30% interest per annum on the total balance. To date, the Company has not recovered any payments against the accounts receivable.                        
Accrued expenses               1,500,000                
Due to related party               6,500,000                
Debt instrument face amount $ 10,850,000 $ 1,600,000                            
Debt instrument conversion price   $ 2.58                            
Warrant to purchase common stock   $ 2.58                            
Warrants exchanged for shares   100,000               29,518            
Debt instrument periodic payment     $ 400,000                          
Loan outstanding                         $ 200,000  
Alcimede LLC [Member]                                
Debt instrument maturity date           Feb. 02, 2016                    
Common stock exercise price         $ 2.50                      
Due from related party                               $ 3,000,000
Debt instrument interest rate                               6.00%
Debt instrument extended due date           Aug. 02, 2017                    
Loan outstanding         $ 2,500,000                      
Repayment of common stock         $ 300,000                      
Mr Lagan [Member]                                
Repayment of debt             $ 50,000 100,000                
Debt instrument extended due date             Feb. 02, 2018                  
Stockholder [Member]                                
Due to related party               75,000                
Mr Diamantis [Member]                                
Due to related party               $ 200,000                
Debt instrument face amount                       $ 3,800,000        
Warrants exchanged for shares                       415,000        
Debt instrument interest rate               10.00% 10.00%              
TCA Debenture [Member]                                
Repayment of debt 750,000                              
Accrued and unpaid interest 100,000 $ 400,000                            
Debt instrument fee $ 150,000                              
Debt instrument maturity date Jun. 27, 2017                              
TCA Debenture [Member] | April 2017 Through September 2017 [Member]                                
Repayment of debt $ 2,600,000                              
September 2016 Notes [Member]                                
Debt instrument conversion price                           $ 7.50    
Warrant to purchase common stock                           66,667    
Common stock exercise price                           $ 12.00    
Warrants exchanged for shares                     400,000          
September 2016 Notes [Member] | Two Investor [Member]                                
Debt instrument face amount                           $ 400,000